RWE AG
OTC:RWNFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
RWE AG
OTC:RWNFF
|
DE |
|
N
|
NovaBay Pharmaceuticals Inc
XBER:B9P
|
US |
|
Exail Technologies
OTC:EXALF
|
FR |
Wall St Price Targets
RWNFF Price Targets Summary
RWE AG
According to Wall Street analysts, the average 1-year price target for RWNFF is 72.29 USD with a low forecast of 41.87 USD and a high forecast of 86.09 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RWNFF's stock price target?
Price Target
72.29
USD
According to Wall Street analysts, the average 1-year price target for RWNFF is 72.29 USD with a low forecast of 41.87 USD and a high forecast of 86.09 USD.
What is the Revenue forecast for RWE AG?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been -8%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for RWE AG?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for RWE AG?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 6 years is 29%.
What is the Pre-Tax Income forecast for RWE AG?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for RWE AG?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 6 years is 0%.
